Publicaciones en las que colabora con AMAIA MAITE ERDOZAIN FERNANDEZ (21)

2024

  1. Effect of antipsychotic drugs on group II metabotropic glutamate receptor expression and epigenetic control in postmortem brains of schizophrenia subjects

    Translational Psychiatry, Vol. 14, Núm. 1

2023

  1. The Matricellular Protein Hevin Is Involved in Alcohol Use Disorder

    Biomolecules, Vol. 13, Núm. 2

2021

  1. Characterization of Hevin (SPARCL1) Immunoreactivity in Postmortem Human Brain Homogenates

    Neuroscience, Vol. 467, pp. 91-109

  2. Spinophilin expression in postmortem prefrontal cortex of schizophrenic subjects: Effects of antipsychotic treatment

    European Neuropsychopharmacology, Vol. 42, pp. 12-21

  3. α2A- and α2C-adrenoceptor expression and functionality in postmortem prefrontal cortex of schizophrenia subjects

    European Neuropsychopharmacology, Vol. 52, pp. 3-11

2019

  1. Differential α 2A - and α 2C -adrenoceptor protein expression in presynaptic and postsynaptic density fractions of postmortem human prefrontal cortex

    Journal of Psychopharmacology, Vol. 33, Núm. 2, pp. 244-249

  2. Cartography of hevin-expressing cells in the adult brain reveals prominent expression in astrocytes and parvalbumin neurons

    Brain Structure and Function, Vol. 224, Núm. 3, pp. 1219-1244

2018

  1. Characterisation of spinophilin immunoreactivity in postmortem human brain homogenates

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 81, pp. 236-242

  2. The loss of α-and β-tubulin proteins are a pathological hallmark of chronic alcohol consumption and natural brain ageing

    Brain Sciences, Vol. 8, Núm. 9

2017

  1. Neuroprotective Effects of a Structurally New Family of High Affinity Imidazoline I2 Receptor Ligands

    ACS Chemical Neuroscience, Vol. 8, Núm. 4, pp. 737-742

2015

  1. Altered CB1 receptor coupling to G-proteins in the post-mortem caudate nucleus and cerebellum of alcoholic subjects

    Journal of Psychopharmacology, Vol. 29, Núm. 11, pp. 1137-1145

  2. The endocannabinoid system is altered in the post-mortem prefrontal cortex of alcoholic subjects

    Addiction Biology, Vol. 20, Núm. 4, pp. 773-783

2014

  1. Alcohol-related brain damage in humans

    PLoS ONE, Vol. 9, Núm. 4

  2. Combining rimonabant and fentanyl in a single entity: Preparation and pharmacological results

    Drug Design, Development and Therapy, Vol. 8, pp. 263-277

  3. Neurobiological alterations in alcohol addiction: a review

    Adicciones: Revista de socidrogalcohol, Vol. 26, Núm. 4, pp. 360-370

2012

  1. The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: Evidence from postmortem human brain

    Biochemical Pharmacology, Vol. 83, Núm. 2, pp. 260-268

2011

  1. Involvement of the endocannabinoid system in alcohol dependence: The biochemical, behavioral and genetic evidence

    Drug and Alcohol Dependence, Vol. 117, Núm. 2-3, pp. 102-110

2009

  1. Implicación del sistema cannabinoide endógeno en el alcoholismo

    Trastornos adictivos: Organo Oficial de la Sociedad española de Toxicomanías, Vol. 11, Núm. 2, pp. 85-95

  2. ¿Es realmente el consumo de cannabis un factor de riesgo para la esquizofrenia?

    Norte de Salud Mental, Vol. 8, Núm. 34, pp. 23-33

2008

  1. Guanidine and 2-aminoimidazoline aromatic derivatives as α2-adrenoceptor antagonists. 2. Exploring alkyl linkers for new antidepressants

    Journal of Medicinal Chemistry, Vol. 51, Núm. 11, pp. 3304-3312